Form 4: Bessemer Venture Partners Sells Hinge Health Shares

Director Elliott Robinson reports the sale of Hinge Health Class A Common Stock by Bessemer Venture Partners funds.

Summary

• Reporting person Elliott Robinson, a director at Hinge Health, disclosed the sale of Class A Common Stock held by Bessemer Venture Partners funds.
• Sales occurred over three days: June 10, June 11, and June 12, 2026.
• Total shares sold across the three-day period amounted to 105,379 shares.
• The transactions were executed at weighted average prices ranging from $65.20 to $66.02 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine disclosure of institutional portfolio rebalancing rather than a signal of operational distress or strategic shift.

Positives

• The sales were executed at prices between $65.00 and $66.45, reflecting a stable market valuation for the shares during the period.

Negatives

• The sale of shares by a director and major institutional investor may be perceived by some market participants as a lack of long-term confidence or a reduction in institutional support.

Risks

• Future sales by major institutional shareholders could exert downward pressure on the stock price.

Future Outlook

No specific forward-looking guidance regarding company operations or future stock performance was provided in this filing.

Management Comments

• The reporting person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest.

Industry Context

StockSavvy.ai notes that institutional divestment by venture capital firms is a standard lifecycle event for portfolio companies post-IPO or after a significant holding period, and does not necessarily reflect on the underlying operational health of the business.

Comparison to Industry Standards

• The filing follows standard SEC disclosure requirements for Section 16 reporting persons.
• The use of weighted average pricing for multiple transactions is consistent with standard institutional trading practices.

Related Party Transactions

• The reporting person is a partner at Bessemer Venture Partners and has an indirect economic interest in the shares held by the Bessemer Funds.

Stakeholder Impact

• Shareholders should note the reduction in holdings by a major institutional investor, though this is common for venture capital firms.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Hinge Health, HNGE, Insider Trading, Bessemer Venture Partners, Form 4, SEC Filing